Taiwan FDA registration b2b453b04cded11e60e24158871b161f
"Bexister" Direct HDL Liquid Reagent (Sterilization)
TW: "百希斯特" 直接高密度脂蛋白液體試劑 (滅菌)
Taiwan·Risk Class 1·BIOSYSTEMS S.A.·Registered Aug 25, 2011 – Aug 25, 2016CancelledRegistration details
- Analysis ID
- b2b453b04cded11e60e24158871b161f
- Customs Code
- DHA04401075401
Company information
- Manufacturer
- BIOSYSTEMS S.A.
- Manufacturer Country
- Spain
- Authorized Representative
- HONEST MEDICAL INC.
Product details
- Intended Use
- Limited to the first level recognition range of the lipoprotein test system (A.1475) of the medical device management method.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1475 Lipoprotein Testing System
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Aug 25, 2011
- Expiry Date
- Aug 25, 2016
- Cancellation Date
- Aug 09, 2018
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Bexister" Direct HDL Liquid Reagent (Sterilization) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b2b453b04cded11e60e24158871b161f and manufactured by BIOSYSTEMS S.A.. The authorized representative in Taiwan is HONEST MEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices